Inventor · disambiguated record
Hong Qin
Also filed as: QIN HONG
6 granted patents·6 pending applications·6 citations·filing 2017–2024
74Inventor score
Top patents by PatentIndex Score
12 records- 0185US12215162B2BAFF-R targeted chimeric antigen receptor-modified T-cells and uses thereofHOPE CITY·Filed 2021·Granted Feb 4, 2025·1 cites·17 claims
- 0285US11981740B2BAFF-R antibodies and uses thereofHOPE CITY·Filed 2021·Granted May 14, 2024·1 cites·20 claims
- 0385US11136405B2BAFF-R antibodies and uses thereofHOPE CITY·Filed 2017·Granted Oct 5, 2021·3 cites·14 claims
- 0477US11161908B2BAFF-R targeted chimeric antigen receptor-modified t-cells and uses thereofHOPE CITY·Filed 2017·Granted Nov 2, 2021·1 cites·25 claims
- 0576US2025092149A1Baff-r targeted chimeric antigen receptor-modified t-cells and uses thereofHOPE CITY·Filed 2024·Application pending·0 cites
- 0675US2024287200A1Baff-r antibodies and uses thereofHOPE CITY·Filed 2024·Application pending·0 cites
- 0767US2024417504A1Vegetable oil polyol, preparation method therefor, and use thereofNANJING UNIVERSITY OF TECHNOLOGY·Filed 2024·Application pending·0 cites
- 0858US2020199232A1Baff-r bispecific t-cell engager antibodyHOPE CITY·Filed 2019·Application pending·0 cites
- 0953US11680102B2Anti-BAFF receptor antibodies and uses thereofYINNUOLAI BIOTECH LTD·Filed 2021·Granted Jun 20, 2023·0 cites·11 claims
- 1053US11597774B2Antibody variable domains and antibody constructsHOPE CITY·Filed 2018·Granted Mar 7, 2023·0 cites·16 claims
- 1151US2022056132A1Baff-r bispecific t-cell engager antibodyHOPE CITY·Filed 2019·Application pending·0 cites
- 1240US2020354452A1Cars and bispecific antibodies for treatment of mantle cell lymphomaHOPE CITY·Filed 2018·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Hong Qin files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →